Hap Trading, LLC Acadia Pharmaceuticals Inc Transaction History

Hap Trading, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $253,478 - $408,977	-15,097 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$15.78 - $24.77 $1.06 Million - $1.67 Million	-67,340 Reduced 81.69%	15,097 $251,000
Q2 2018 Aug 13, 2018	BUY	$15.07 - $22.34 $1.24 Million - $1.84 Million	82,437 New	82,437 $1.26 Million

299

158M

1.88M

688K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.